1-9 of 9
Pierre Brissot
Close
Sort by
Journal Articles

Hemochromatosis classification: update and recommendations by the BIOIRON Society

Domenico Girelli, Fabiana Busti, Pierre Brissot, Ioav Cabantchik, Martina U. Muckenthaler, Graça Porto
Journal: Blood
Blood (2022) 139 (20): 3018–3029.
https://doi.org/10.1182/blood.2021011338
Published: 2022
Includes: Supplemental data
Journal Articles

Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload

Yves Deugnier, MD, Bruno Turlin, MD, PhD, Victor Dong, MD, Vanessa Giannone, BSN, Yiyun Zhang, PhD, Louis Griffel, MD, Pierre Brissot, MD
Journal: Blood
Blood (2010) 116 (21): 4274.
https://doi.org/10.1182/blood.V116.21.4274.4274
Published: 2010
Journal Articles

Iron Overload Diagnosis and Management Among Clinicians: International Survey Showing Gaps In Knowledge and Need for Continuing Educational Programs

Maria Domenica Cappellini, MD, Photis Beris, Pierre Brissot, MD, John B. Porter, MD, Ali Taher, MD, Patty Peterson, CCMEP, Elaine Rudell, CCMEP
Journal: Blood
Blood (2010) 116 (21): 2562.
https://doi.org/10.1182/blood.V116.21.2562.2562
Published: 2010
Journal Articles

A Phase I/II, Open-Label, Dose-Escalation Trial of Once-Daily Oral Chelator Deferasirox to Treat Iron Overload in HFE-Related Hereditary Hemochromatosis: Final Results of the Core Study.

Pradyumna D. Phatak, Pierre Brissot, Herbert Bonkovsky, Mark Wurster, Lawrie Powell, Claus Niederau, Paul Adams, Wolfgang Stremmel, Louis Griffel, Nicola Lynch, Oliver Schoenborn-Kellenberger, Antonello Pietrangelo
Journal: Blood
Blood (2009) 114 (22): 1514.
https://doi.org/10.1182/blood.V114.22.1514.1514
Published: 2009
Journal Articles

Iron excess treatable by copper supplementation in acquired aceruloplasminemia: a new form of secondary human iron overload?

Dorothée Videt-Gibou, Serge Belliard, Edouard Bardou-Jacquet, Marie-Bérengère Troadec, Caroline Le Lan, Anne-Marie Jouanolle, Olivier Loréal, Joseph Rivalan, Pierre Brissot
Journal: Blood
Blood (2009) 114 (11): 2360–2361.
https://doi.org/10.1182/blood-2009-06-226175
Published: 2009
Journal Articles

Comparative Effect of the Oral Iron Chelators ICL670A and CP20 on Cell Proliferation, Apoptosis and Polyamine Metabolism in Rat and Human Liver Cell Cultures.

François Gaboriau, PhD, Karine Chantrel-Groussard, PhD, Nicole Pasdeloup, Hans Peter Nick, Pierre Brissot, Gérard Lescoat, PhD
Journal: Blood
Blood (2005) 106 (11): 4448.
https://doi.org/10.1182/blood.V106.11.4448.4448
Published: 2005
Journal Articles

Altered Hepcidin Regulation in Hereditary Hemochromatosis and Dysmetabolic Hyperferritinemia.

Elizabeta Nemeth, Olivier Loreal, Caroline Le Lan, Martine Ropert, Marie-Bérengère Troadec, Lénaïck Detivaud, Christine Jard, Michele Pouchard, André Le Treut, Yves Deugnier, Tomas Ganz, Pierre Brissot
Journal: Blood
Blood (2005) 106 (11): 3590.
https://doi.org/10.1182/blood.V106.11.3590.3590
Published: 2005
Journal Articles

Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function

Clinical Trials & Observations Brief Report
Lénaïck Détivaud, Elizabeta Nemeth, Karim Boudjema, Bruno Turlin, Marie-Bérengère Troadec, Patricia Leroyer, Martine Ropert, Sylvie Jacquelinet, Brice Courselaud, Tomas Ganz, Pierre Brissot, Olivier Loréal
Journal: Blood
Blood (2005) 106 (2): 746–748.
https://doi.org/10.1182/blood-2004-12-4855
Published: 2005
Journal Articles

Redox active plasma iron in C282Y/C282Y hemochromatosis

Clinical Trials & Observations
Caroline Le Lan, Olivier Loréal, Tally Cohen, Martine Ropert, Hava Glickstein, Fabrice Lainé, Michel Pouchard, Yves Deugnier, André Le Treut, William Breuer, Z. Ioav Cabantchik, Pierre Brissot
Journal: Blood
Blood (2005) 105 (11): 4527–4531.
https://doi.org/10.1182/blood-2004-09-3468
Published: 2005